Asia-Pacific IVF Services Market by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Analysis and Industry Forecast, 2020–2028
- ALL4220423
- 375 Pages
- February 2021
- Medical Devices
IVF is a complex series of procedures used to help unfertile population and assist with them with conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab. The Asia-Pacific IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rates, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income in the region. However, complications associated with IVF treatment and lower awareness regarding IVF in some under developed regions hinders growth of the market. Furthermore, surge in fertility tourism, increase in number of fertility clinics, and growth opportunities in emerging markets make way for development of the Asia-Pacific IVF market in the future.
Asia-Pacific presents productive opportunities for players operating in the IVF services market, owing to its high population base, growth in knowledge about IVF treatment, low costs of IVF treatments, delayed pregnancy trends, rise in number of infertile populations, and surge in disposable income. In older women (more than 40 years age group), eggs produced by the reproductive system are not fully prepared for the process of fertilization. This may result in risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in production of healthy eggs and increased chances of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to drive growth of the IVF services market.
The Asia-Pacific IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, the Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
It offers a quantitative analysis from 2018 to 2028, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled to understand the competitive outlook of the Asia-Pacific market.
KEY MARKET SEGMENTS
By Cycle Type
• Fresh IVF Cycles (Non-Donor)
• Thawed IVF Cycles (Non-Donor)
• Donor Egg IVF Cycles
By End User
• Fertility Clinics
• Hospitals
• Surgical centers
• Clinical research institutes
By Country
• Asia Pacific
o Japan
o India
o China
o Australia
o New Zealand
o South Korea
o Thailand
o Singapore
o Malaysia
o Indonesia
o Philippines
o Vietnam
o Myanmar
o Rest of Asia-Pacific
LIST OF KEY PLAYERS PROFILED IN THE REPORT
The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.
1.1.Report Description
1.2.Key Benefits for Stakeholders
1.3.Key Market Segments
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key Findings of the Study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market Definition and Scope
3.2.Asia-Pacific IVF Services Market, By End User
3.2.1.Market size and forecast
3.2.2.Market volume and forecast
3.2.3.Fertility clinics
3.2.3.1.Market size and forecast
3.2.4.Hospitals
3.2.4.1.Market size and forecast
3.2.5.Surgical centers
3.2.5.1.Market size and forecast
3.2.6.Clinical research institutes
3.2.6.1.Market size and forecast
3.3.Asia-Pacific IVF Services Market, by Cycle Type
3.3.1.Market size and forecast
3.3.2.Market volume and forecast
3.3.3.Fresh IVF cycles (non-donor)
3.3.3.1.Market size and forecast
3.3.4.Thawed IVF cycles (non-donor)
3.3.4.1.Market size and forecast
3.3.5.Donor egg IVF cycles
3.3.5.1.Market size and forecast
3.4.Asia-Pacific IVF services market, by country
3.4.1.Limitations of foreign investment
3.4.1.1.India
3.4.1.2.China
3.4.1.3.Japan
3.4.1.4.Australia
3.4.1.5.New Zealand
3.4.1.6.South Korea
3.4.1.7.Thailand
3.4.1.8.Indonesia
3.4.1.9.Philippines
3.4.1.10.Vietnam
3.4.1.11.Myanmar
3.4.2.Market size and forecast, by country
3.4.3.Market volume and forecast
3.5.Market Dynamics
3.5.1.Drivers
3.5.1.1.Delayed pregnancies in women
3.5.1.2.Increase in infertility rates
3.5.1.3.Rise in gamete donations
3.5.1.4.Surge in disposable income
3.5.1.5.Increase in IVF success rates
3.5.2.Restraints
3.5.2.1.Complications associated with IVF treatment
3.5.2.2.Low awareness level
3.5.3.Opportunities
3.5.3.1.Fertility tourism
3.5.3.2.Growth opportunities in the region
3.5.3.3.Increase in number of fertility clinics
3.5.4.Impact analyses
CHAPTER 4:INDIA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
4.1.Overview
4.1.1.Market size and forecast
4.2.Fertility Center in India
4.3.India IVF Services Market, By End User
4.3.1.Market size and forecast
4.3.2.Market volume and forecast
4.3.3.Fertility clinics
4.3.4.Hospitals
4.3.5.Surgical Centers
4.3.6.Clinical Research Institutes
4.4.India IVF Services Market, By Cycle Type
4.4.1.Market size and forecast
4.4.2.Market volume and forecast
4.4.3.Fresh IVF cycles (non-donor)
4.4.4.Thawed IVF cycles (non-donor)
4.4.5.Donor egg IVF cycles
4.5.Market Dynamics
4.5.1.Drivers
4.5.2.Restrains
4.6.Regulatory Issues, Legislations, and Authorities
4.7.Insurance Reimbursement Scenario
CHAPTER 5:CHINA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
5.1.Overview
5.1.1.Market size and forecast
5.2.China IVF Services Market, By End User
5.2.1.Market size and forecast
5.2.2.Market volume and forecast
5.2.3.Fertility clinics
5.2.4.Hospitals
5.2.5.Surgical Centers
5.2.6.Clinical research institutes
5.3.China IVF Services Market, By Cycle Type
5.3.1.Market size and forecast
5.3.2.Market volume and forecast
5.3.3.Fresh IVF cycles (non-donor)
5.3.4.Thawed IVF cycles (non-donor)
5.4.Market Dynamics
5.4.1.Drivers
5.4.2.Restrains
5.4.3.Regulatory Issues, Legislations, and Authorities
CHAPTER 6:JAPAN IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
6.1.Overview
6.2.Fertility Centers in Japan
6.2.1.Market size and forecast
6.3.Japan IVF services market, by end user
6.3.1.Market size and forecast
6.3.2.Market volume and forecast
6.3.3.Fertility clinics
6.3.4.Hospitals
6.3.5.Surgical Centers
6.3.6.Clinical research institutes
6.4.Japan IVF Services Market, By Cycle Type
6.4.1.Market size and forecast
6.4.2.Market volume and forecast
6.4.3.Fresh IVF cycles (non-donor)
6.4.4.Thawed IVF cycles (non-donor)
6.4.5.Donor egg IVF cycles
6.5.Market Dynamics
6.5.1.Drivers
6.5.2.Restraints
6.6.Regulatory Issues, Legislations, and Authorities
6.7.Insurance Reimbursement Scenario
CHAPTER 7:AUSTRALIA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
7.1.Overview
7.1.1.Market size and forecast
7.2.Fertility Centers in Australia
7.3.Australia IVF Services Market, By End User
7.3.1.Market size and forecast
7.3.2.Market volume and forecast
7.3.3.Fertility clinics
7.3.4.Hospitals
7.3.5.Surgical Centers
7.3.6.Clinical research institutes
7.4.Australia IVF Services Market, By Cycle Type
7.4.1.Market size and forecast
7.4.2.Market volume and forecast
7.4.3.Fresh IVF cycles (non-donor)
7.4.4.Thawed IVF cycles (non-donor)
7.4.5.Donor egg IVF cycles
7.5.Market Dynamics
7.5.1.Drivers
7.5.2.Restraints
7.6.Regulatory Issues, Legislations, and Authorities
7.7.Insurance Reimbursement Scenario
CHAPTER 8:NEW ZEALAND IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
8.1.Overview
8.1.1.Market size and forecast
8.2.New Zealand IVF Services Market, By End User
8.2.1.Market size and forecast
8.2.2.Market volume and forecast
8.2.3.Fertility clinics
8.2.4.Hospitals
8.2.5.Surgical Centers
8.2.6.Clinical research institutes
8.3.New Zealand IVF Services Market, By Cycle Type
8.3.1.Market size and forecast
8.3.2.Market volume and forecast
8.3.3.Fresh IVF cycles (non-donor)
8.3.4.Thawed IVF cycles (non-donor)
8.3.5.Donor egg IVF cycles
8.4.Market Dynamics
8.4.1.Drivers
8.4.2.Restraints
8.5.Regulatory Issues, Legislations and Authorities
8.6.Insurance Reimbursement Scenario
CHAPTER 9:SOUTH KOREA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
9.1.Overview
9.1.1.Market size and forecast
9.2.Fertility Centers in South Korea
9.3.South Korea IVF Services Market, By End User
9.3.1.Market size and forecast
9.3.2.Market volume and forecast
9.3.3.Fertility clinics
9.3.4.Hospitals
9.3.5.Surgical Centers
9.3.6.Clinical research institutes
9.4.South Korea IVF Services Market, By Cycle Type
9.4.1.Market size and forecast
9.4.2.Market volume and forecast
9.4.3.Fresh IVF cycles (non-donor)
9.4.4.Thawed IVF cycles (non-donor)
9.4.5.Donor egg IVF cycles
9.5.Market Dynamics
9.5.1.Drivers
9.5.2.Restraints
9.6.Regulatory Issues, Legislations and Authorities
9.7.Insurance Reimbursement Scenario
CHAPTER 10:THAILAND IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
10.1.Overview
10.1.1.Market size and forecast
10.2.Thailand IVF Services Market, By End User
10.2.1.Market size and forecast
10.2.2.Market volume and forecast
10.2.3.Fertility Clinics
10.2.4.Hospitals
10.2.5.Surgical Centers
10.2.6.Clinical Research Institutes
10.3.Thailand IVF Services Market, By Cycle Type
10.3.1.Market size and forecast
10.3.2.Market volume and forecast
10.3.3.Fresh IVF cycles (non-donor)
10.3.4.Thawed IVF cycles (non-donor)
10.3.5.Donor egg IVF cycles
10.4.Market Dynamics
10.4.1.Drivers
10.4.2.Restraints
10.5.Regulatory Issues, Legislations, and Authorities
10.6.Insurance Reimbursement Scenario
CHAPTER 11:SINGAPORE IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
11.1.Overview
11.1.1.Market size and forecast
11.2.Singapore IVF Services Market, By End User
11.2.1.Market size and forecast
11.2.2.Market volume and forecast
11.2.3.Fertility Clinics
11.2.4.Hospitals
11.2.5.Surgical Centers
11.2.6.Clinical research institutes
11.3.Singapore IVF Services Market, By Cycle Type
11.3.1.Market size and forecast
11.3.2.Market volume and forecast
11.3.3.Fresh IVF cycles (non-donor)
11.3.4.Thawed IVF cycles (non-donor)
11.3.5.Donor egg IVF cycles
11.4.Market Dynamics
11.4.1.Drivers
11.4.2.Restraints
11.5.Regulatory Issues, Legislations, and Authorities
11.6.Insurance Reimbursement Scenario
CHAPTER 12:MALAYSIA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
12.1.Overview
12.1.1.Market size and forecast
12.2.Malaysia IVF Services Market, By End User
12.2.1.Market size and forecast
12.2.2.Market volume and forecast
12.2.3.Fertility clinics
12.2.4.Hospitals
12.2.5.Surgical Centers
12.2.6.Clinical research institutes
12.3.Malaysia IVF Services Market, By Cycle Type
12.3.1.Market size and forecast
12.3.2.Market volume and forecast
12.3.3.Fresh IVF cycles (non-donor)
12.3.4.Thawed IVF cycles (non-donor)
12.3.5.Donor egg IVF cycles
12.4.Market Dynamics
12.4.1.Drivers
12.4.2.Restraints
12.5.Regulatory Issues, Legislations, and Authorities
12.6.Insurance Reimbursement Scenario
CHAPTER 13:INDONESIA IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
13.1.Overview
13.1.1.Market size and forecast
13.2.Indonesia IVF Services Market, By End User
13.2.1.Market size and forecast
13.2.2.Market volume and forecast
13.2.3.Fertility clinics
13.2.4.Hospitals
13.2.5.Surgical Centers
13.2.6.Clinical research institutes
13.3.Indonesia IVF Services Market, By Cycle Type
13.3.1.Market size and forecast
13.3.2.Market volume and forecast
13.3.3.Fresh IVF cycles (non-donor)
13.3.4.Thawed IVF cycles (non-donor)
13.3.5.Donor egg IVF cycles
13.4.Market Dynamics
13.4.1.Drivers
13.4.2.Restraints
13.5.Regulatory Issues, Legislations, and Authorities
13.6.Insurance Reimbursement Scenario
CHAPTER 14:PHILIPPINES IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
14.1.Overview
14.1.1.Market size and forecast
14.2.Philippines IVF Services Market, By End User
14.2.1.Market size and forecast
14.2.2.Market volume and forecast
14.2.3.Fertility clinics
14.2.4.Hospitals
14.2.5.Surgical Centers
14.2.6.Clinical research institutes
14.3.Philippines IVF Services Market, By Cycle Type
14.3.1.Market size and forecast
14.3.2.Market volume and forecast
14.3.3.Fresh IVF cycles (non-donor)
14.3.4.Thawed IVF cycles (non-donor)
14.3.5.Donor egg IVF cycles
14.4.Market Dynamics
14.4.1.Drivers
14.4.2.Restraints
14.5.Regulatory Issues, Legislations, and Authorities
14.6.Insurance Reimbursement Scenario
CHAPTER 15:VIETNAM IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
15.1.Overview
15.1.1.Market size and forecast
15.2.Vietnam IVF Services Market, By End User
15.2.1.Market size and forecast
15.2.2.Market volume and forecast
15.2.3.Fertility clinics
15.2.4.Hospitals
15.2.5.Surgical Centers
15.2.6.Clinical research institutes
15.3.Vietnam IVF Services Market, By Cycle Type
15.3.1.Market size and forecast
15.3.2.Market volume and forecast
15.3.3.Fresh IVF cycles (non-donor)
15.3.4.Thawed IVF cycles (non-donor)
15.3.5.Donor egg IVF cycles
15.4.Market Dynamics
15.4.1.Drivers
15.4.2.Restraints
15.5.Regulatory Issues, Legislations, and Authorities
15.6.Insurance Reimbursement Scenario
CHAPTER 16:MYANMAR IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
16.1.Overview
16.2.Market size and forecast
16.3.Myanmar IVF Services Market, By End User
16.3.1.Market size and forecast
16.3.2.Market volume and forecast
16.3.3.Fertility clinics
16.3.4.Hospitals
16.3.5.Surgical centers
16.3.6.Clinical research institutes
16.4.Myanmar IVF Services Market, By Cycle Type
16.4.1.Market size and forecast
16.4.2.Market volume and forecast
16.4.3.Fresh IVF cycles (non-donor)
16.4.4.Thawed IVF cycles (non-donor)
16.5.Market Dynamics
16.5.1.Drivers
16.5.2.Restraining factors
16.6.Regulatory Issues, Legislations, and Authorities
16.7.Insurance Reimbursement Scenario
CHAPTER 17:REST OF ASIA-PACIFIC IVF SERVICES MARKET, REVENUE AND NUMBER OF CYCLES
17.1.Overview
17.1.1.Market size and forecast
17.2.Rest of Asia-Pacific IVF Services Market, By End User
17.2.1.Market size and forecast
17.2.2.Market volume and forecast
17.2.3.Fertility clinics
17.2.4.Hospitals
17.2.5.Surgical centers
17.2.6.Clinical research institutes
17.3.Rest of Asia-Pacific IVF Services Market, By Cycle Type
17.3.1.Market size and forecast
17.3.2.Market volume and forecast
17.3.3.Fresh IVF cycles (non-donor)
17.3.4.Thawed IVF cycles (non-donor)
17.3.5.Donor egg IVF cycles
17.4.Market Dynamics
17.4.1.Drivers
17.4.2.Restraining factors
17.5.Regulatory Issues, Legislations, And Authorities
17.6.Insurance Reimbursement Scenario
CHAPTER 18:COMPANY PROFILES (INDIA)
18.1.Company Profiles (India)
18.1.1.Bourn Hall Fertility Center
18.1.1.1.Company overview
18.1.2.Southend Fertility and IVF
18.1.2.1.Company overview
18.1.3.Morpheus Life Sciences Pvt. Ltd.
18.1.3.1.Company overview
18.1.4.Bloom Fertility Center
18.1.4.1.Company overview
18.1.5.Bloom Fertility and Healthcare
18.1.5.1.Company overview
18.1.6.Manipal Fertility
18.1.6.1.Company overview
18.1.7.Cloudnine Fertility
18.1.7.1.Company overview
18.1.8.Chennai Fertility Center
18.1.8.1.Company overview
18.2.Company Profiles (China)
18.2.1.Shanghai Ji Ai Genetics & IVF Institute
18.2.1.1.Company overview
18.2.2.Shanghai United Family Hospital
18.2.2.1.Company overview
18.3.Company Profiles (Japan)
18.3.1.IVF NAMBA Clinic
18.3.1.1.Company overview
18.3.2.Sanno Hospital
18.3.2.1.Company overview
18.3.3.Oak Medical Group/Oak Clinic
18.3.3.1.Company overview
18.4.Company Profiles (Australia)
18.4.1.Virtus Health
18.4.1.1.Company overview
18.4.1.2.Business performance
18.4.2.Monash IVF Group
18.4.2.1.Company overview
18.4.3.Fertility First
18.4.3.1.Company overview
18.4.4.Flinders Reproductive Medicine Pty Ltd
18.4.4.1.Company overview
18.5.Company Profiles (New Zealand)
18.5.1.Fertility Associates
18.5.1.1.Company overview
18.5.2.Genea Oxford Fertility Limited
18.5.2.1.Company overview
18.5.3.Repromed
18.5.3.1.Company overview
18.6.Company Profiles (South Korea)
18.6.1.CHA Fertility Center
18.6.1.1.Company overview
18.6.2.Maria Fertility Hospital
18.6.2.1.Company overview
18.7.Company Profiles (Thailand)
18.7.1.SAFE Fertility Center
18.7.1.1.Company overview
18.7.2.Bangkok IVF Center (Bangkok Hospital)
18.7.2.1.Company overview
18.7.3.Business performance
18.7.4.Bangkok IVF center
18.7.4.1.Company overview
18.7.5.Superior A.R.T
18.7.5.1.Company overview
18.8.Company Profiles (Singapore)
18.8.1.National University Hospital
18.8.1.1.Company overview
18.8.2.IHH Healthcare Berhad
18.8.2.1.Company overview
18.8.3.Operating business segments
18.8.4.Business performance
18.8.5.Thomson Medical Pte. Ltd.
18.8.5.1.Company overview
18.8.6.Raffles Medical Group
18.8.6.1.Company overview
18.8.7.Operating business segments
18.8.8.Business performance
18.9.Company Profiles (Malaysia)
18.9.1.Damai Service Hospital
18.9.1.1.Company overview
18.9.2.TMC Fertility Centre
18.9.2.1.Company overview
18.9.3.KL Fertility & Gynecology Centre
18.9.3.1.Company overview
18.10.Company Profiles (Indonesia)
18.10.1.Morula IVF
18.10.1.1.Company overview
18.10.2.Lotus Fertility Clinic
18.10.2.1.Company overview
18.10.3.RSUP Dr. Hasan Sadikin Bandung
18.10.3.1.Company overview
18.11.Company Profiles (Philippines)
18.11.1.Victory A.R.T. Laboratory Phils., Inc.
18.11.1.1.Company overview
18.11.2.Center for Advanced Reproductive Medicine and Infertility
18.11.2.1.Company overview
18.12.Company Profiles (Vietnam)
18.12.1.IVF Van Hanh
18.12.1.1.Company overview
18.12.2.Tu Du Hospital
18.12.2.1.Company overview
18.13.Company Profiles (Myanmar)
18.13.1.Bahosi Fertility Centre
18.13.1.1.Company overview
18.13.2.Bumrungrad International Hospital
18.13.2.1.Company overview
18.13.3.Business performance
18.14.Company List (Rest of APAC)
TABLE 01.ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 02.ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 03.ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 04.ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 05.ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY COUNTRY, 2018–2028 ($MILLION)
TABLE 06.ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY COUNTRY, 2018–2028 (THOUSAND)
TABLE 07.LIST OF A FEW FERTILITY CENTERS IN INDIA
TABLE 08.INDIA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 09.INDIA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 10.INDIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 11.INDIA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 12.CHINA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 13.CHINA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 14.CHINA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 15.CHINA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 16.LIST OF A FEW FERTILITY CENTERS IN JAPAN
TABLE 17.JAPAN IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 18.JAPAN IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 19.JAPAN IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 20.JAPAN IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 21.LIST OF A FEW FERTILITY CENTERS IN AUSTRALIA
TABLE 22.AUSTRALIA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 23.AUSTRALIA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 24.AUSTRALIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 25.AUSTRALIA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 26.NEW ZEALAND IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 27.NEW ZEALAND IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 28.NEW ZEALAND IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 29.NEW ZEALAND IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 30.LIST OF A FEW FERTILITY CENTERS IN SOUTH KOREA
TABLE 31.SOUTH KOREA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 32.SOUTH KOREA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 33.SOUTH KOREA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 34.SOUTH KOREA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 35.THAILAND IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 36.THAILAND IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 37.THAILAND IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 38.THAILAND IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 39.SINGAPORE IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 40.SINGAPORE IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 41.SINGAPORE IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 42.SINGAPORE IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 43.MOH CO-FUNDING RATES IN SINGAPORE
TABLE 44.MEDISAVE LIMITS FOR IVF CYCLES IN SINGAPORE
TABLE 45.MALAYSIA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 46.MALAYSIA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 47.MALAYSIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 48.MALAYSIA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 49.INDONESIA IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 50.INDONESIA IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 51.INDONESIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 52.INDONESIA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 53.PHILIPPINES IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 54.PHILIPPINES IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 55.PHILIPPINES IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 56.PHILIPPINES IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 57.VIETNAM IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 58.VIETNAM IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 59.VIETNAM IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 60.VIETNAM IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 61.MYANMAR IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 62.MYANMAR IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 63.MYANMAR IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 64.MYANMAR IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 65.REST OF ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY END USER, 2018–2028 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY END USER, 2018–2028 (THOUSAND)
TABLE 67.REST OF ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2018–2028 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2018–2028 (THOUSAND)
TABLE 69.BOURN HALL FERTILITY CENTER BUSINESS OVERVIEW
TABLE 70.SNAPSHOT OF BOURN HALL FERTILITY CENTER
TABLE 71.SOUTHEND FERTILITY AND IVF BUSINESS OVERVIEW
TABLE 72.SNAPSHOT OF SOUTHEND FERTILITY AND IVF
TABLE 73.MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
TABLE 74.SNAPSHOT OF MORPHEUS IVF FERTILITY CENTER
TABLE 75.BLOOM FERTILITY CENTER BUSINESS OVERVIEW
TABLE 76.SNAPSHOT OF BLOOM FERTILITY CENTER
TABLE 77.BLOOM FERTILITY AND HEALTHCARE BUSINESS OVERVIEW
TABLE 78.SNAPSHOT OF BLOOM FERTILITY AND HEALTHCARE
TABLE 79.MANIPAL FERTILITY BUSINESS OVERVIEW
TABLE 80.SNAPSHOT OF MANIPAL FERTILITY
TABLE 81.CLOUDNINE FERTILITY BUSINESS OVERVIEW
TABLE 82.SNAPSHOT OF CLOUDNINE FERTILITY
TABLE 83.CHENNAI FERTILITY CENTER: BUSINESS OVERVIEW
TABLE 84.SNAPSHOT OF CHENNAI FERTILITY CENTER
TABLE 85.BUSINESS OVERVIEW OF SHANGHAI JI AI GENETICS & IVF INSTITUTE
TABLE 86.SNAPSHOT OF SHANGHAI JI AI GENETICS & IVF INSTITUTE
TABLE 87.SHANGHAI UNITED FAMILY HOSPITAL BUSINESS OVERVIEW
TABLE 88.SNAPSHOT OF SHANGHAI UNITED FAMILY HOSPITAL
TABLE 89.IVF NAMBA CLINIC BUSINESS OVERVIEW
TABLE 90.SNAPSHOT OF IVF NAMBA CLINIC
TABLE 91.SANNO HOSPITAL BUSINESS OVERVIEW
TABLE 92.SNAPSHOT OF SANNO HOSPITAL
TABLE 93.OAK MEDICAL GROUP BUSINESS OVERVIEW
TABLE 94.SNAPSHOT OF OAK MEDICAL GROUP
TABLE 95.VIRTUS HEALTH BUSINESS OVERVIEW
TABLE 96.SNAPSHOT OF VIRTUS HEALTH
TABLE 97.MONASH IVF GROUP BUSINESS OVERVIEW
TABLE 98.SNAPSHOT OF MONASH IVF WESLEY HOSPITAL AUCHENFLOWER
TABLE 99.FERTILITY FIRST BUSINESS OVERVIEW
TABLE 100.SNAPSHOT OF FERTILITY FIRST
TABLE 101.FLINDERS REPRODUCTIVE MEDICINE PTY LTD BUSINESS OVERVIEW
TABLE 102.SNAPSHOT OF FLINDERS REPRODUCTIVE MEDICINE PTY LTD
TABLE 103.FERTILITY ASSOCIATES BUSINESS OVERVIEW
TABLE 104.SNAPSHOT OF FERTILITY ASSOCIATES
TABLE 105.GENEA OXFORD FERTILITY LIMITED BUSINESS OVERVIEW
TABLE 106.SNAPSHOT OF GENEA OXFORD FERTILITY LIMITED
TABLE 107.REPROMED BUSINESS OVERVIEW
TABLE 108.SNAPSHOT OF REPROMED
TABLE 109.CHA FERTILITY CENTER BUSINESS OVERVIEW
TABLE 110.SNAPSHOT OF CHA FERTILITY CENTER
TABLE 111.MARIA FERTILITY HOSPITAL BUSINESS OVERVIEW
TABLE 112.SNAPSHOT OF MARIA FERTILITY HOSPITAL
TABLE 113.SAFE FERTILITY CENTER: OVERVIEW
TABLE 114.SNAPSHOT OF SAFE FERTILITY CENTER
TABLE 115.BANGKOK IVF CENTER: OVERVIEW
TABLE 116.SNAPSHOT OF BANGKOK IVF CENTER
TABLE 117.BANGKOK IVF CENTER: OVERVIEW
TABLE 118.SNAPSHOT OF BANGKOK IVF CENTER
TABLE 119.SUPERIOR A.R.T: COMPANY OVERVIEW
TABLE 120.SUPERIOR A.R.T: COMPANY SNAPSHOT
TABLE 121.NATIONAL UNIVERSITY HOSPITAL BUSINESS OVERVIEW
TABLE 122.SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 123.IHH HEALTHCARE BERHAD BUSINESS OVERVIEW
TABLE 124.SNAPSHOT OF IHH HEALTHCARE BERHAD
TABLE 125.THOMSON MEDICAL PTE. LTD. BUSINESS OVERVIEW
TABLE 126.SNAPSHOT OF THOMSON MEDICAL PTE. LTD.
TABLE 127.RAFFLES MEDICAL GROUP BUSINESS OVERVIEW
TABLE 128.SNAPSHOT OF RAFFLES MEDICAL GROUP
TABLE 129.RAFFLES MEDICAL GROUP: OPERATING SEGMENTS
TABLE 130.DAMAI SERVICE HOSPITAL BUSINESS OVERVIEW
TABLE 131.SNAPSHOT OF DAMAI SERVICE HOSPITAL
TABLE 132.TMC FERTILITY CENTRE BUSINESS OVERVIEW
TABLE 133.SNAPSHOT OF TMC FERTILITY CENTRE
TABLE 134.KL FERTILITY & GYNECOLOGY CENTRE BUSINESS OVERVIEW
TABLE 135.SNAPSHOT OF THOMSON MEDICAL PTE. LTD.
TABLE 136.MORULA IVF BUSINESS OVERVIEW
TABLE 137.SNAPSHOT OF MORULA IVF
TABLE 138.LOTUS FERTILITY CLINIC BUSINESS OVERVIEW
TABLE 139.SNAPSHOT OF LOTUS FERTILITY CLINIC
TABLE 140.RSUP DR. HASAN SADIKIN BANDUNGBUSINESS OVERVIEW
TABLE 141.SNAPSHOT OF RSUP DR. HASAN SADIKIN BANDUNG
TABLE 142.VICTORY A.R.T. LABORATORY PHILS., INC. OVERVIEW
TABLE 143.SNAPSHOT OF VICTORY A.R.T. LABORATORY PHILS., INC.
TABLE 144.CENTER FOR ADVANCED REPRODUCTIVE MEDICINE AND INFERTILITY BUSINESS OVERVIEW
TABLE 145.SNAPSHOT OF CENTER FOR ADVANCED REPRODUCTIVE MEDICINE AND INFERTILITY
TABLE 146.IVF VAN HANH BUSINESS OVERVIEW
TABLE 147.SNAPSHOT OF IVF VAN HANH
TABLE 148.TU DU HOSPITAL BUSINESS OVERVIEW
TABLE 149.SNAPSHOT OF TU DU HOSPITAL
TABLE 150.BFC: COMPANY OVERVIEW
TABLE 151.BFC: COMPANY SNAPSHOT
TABLE 152.BUMRUNGRAD INTERNATIONAL HOSPITAL: COMPANY OVERVIEW
TABLE 153.BUMRUNGRAD INTERNATIONAL HOSPITAL: COMPANY SNAPSHOT
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
